Consuelo Bertossi, MD

Articles by Consuelo Bertossi, MD

Consuelo Bertossi, MD

Dr Bertossi on the Role of Centralized Academic Reference Diagnostics and Biobanking in Clinical Trials

ByConsuelo Bertossi, MD

August 14th 2024

Consuelo Bertossi, MD, discusses centralized academic reference diagnostics and biobanking in prospective, multicenter clinical trials.

Consuelo Bertossi, MD

Dr Bertossi on the Prognostic Role of TP53 Mutations in CLL

ByConsuelo Bertossi, MD

June 15th 2024

Consuelo Bertossi, MD, discusses the role of TP53 mutations and their prognostic significance in chronic lymphocytic leukemia.

Latest Updated Articles

Dr Bertossi on the Role of Centralized Academic Reference Diagnostics and Biobanking in Clinical Trials
August 14th 2024
Dr Bertossi on the Prognostic Role of TP53 Mutations in CLL
June 15th 2024

Trending on OncLive

Adjuvant Giredestrant Preserves QOL With Sustained Tolerability in ER+, HER2– Early Breast Cancer

Arcotatug Tavatecan Improves Survival in CLDN18.2+ Advanced Gastric or GEJ Adenocarcinoma

Sacituzumab Govitecan Triplet Elicits Durable Responses in Treatment-Naive Metastatic Urothelial Cancer

Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves ctDNA Clearance in Cisplatin-Eligible MIBC

Ad Hoc Analysis Supports Contributions of Both Enfortumab Vedotin and Pembrolizumab in Cisplatin-Ineligible MIBC